Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules

Last updated: February 13, 2025
Sponsor: Chinese PLA General Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Thyroid Disease

Treatment

ultrasound-guided thermal ablation

Clinical Study ID

NCT06733753
2024-656
  • Ages > 18
  • All Genders

Study Summary

To evaluate the long-term outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. confirmation of Bethesda III or IV on fine- needle aspiration and negative on BrafV600E test

  2. no clinical or imaging evidences of extrathyroidal extension, lymph node metastasisand distant metastasis on ultrasound, neck and chest CT

  3. refusal or ineligibility for surgery

  4. follow-up time ≥12 months

Exclusion

Exclusion Criteria:

  1. follicular neoplasm or malignancy findings on biopsy

  2. no suspicious of malignancy in US

  3. patients with contra-lateral vocal cord paralysis

  4. follow- up time less than 12 months

Study Design

Total Participants: 600
Treatment Group(s): 1
Primary Treatment: ultrasound-guided thermal ablation
Phase:
Study Start date:
December 09, 2024
Estimated Completion Date:
December 31, 2030

Study Description

To evaluate and predict the long-term clinical outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules

Connect with a study center

  • Chinese PLA General Hospital

    Beijing, Beijing 100853
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.